-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
January 01, 2019 - Defining an Optimal Format for Presenting Research Needs
Methods Future Research Needs Report
Number … 3
Defining an Optimal Format
for Presenting Research Needs
Methods Future … Research Needs Report
Number 3
Defining an Optimal Format
for Presenting Research Needs … Methods Research on
Future Research Needs: Defining an Optimal Format for Presenting Research Needs … Agency for Healthcare Research and Quality
iv
Methods Research on Future Research Needs:
Defining
-
effectivehealthcare.ahrq.gov/sites/default/files/investing_elwyn_presentation.pdf
January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm)
Slide
1:
Investing
in
deliberation:
defining … about
options,
by
considering
relevant
attributes;
Slide
20:
Defining … long-‐term
outcomes
which
have
relevant
consequences,
Slide
21:
Defining … Slide
22:
Defining
Decision
Support
…
‘Decision
support
interventions … Web
site
(http://www.effectivehealthcare.ahrq.gov/index.cfm)
Slide
23:
Defining
-
effectivehealthcare.ahrq.gov/products/methods-future-presentation-format/research
-
effectivehealthcare.ahrq.gov/products/stakeholder-engagement-benefits/white-paper
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - Other important factors to consider when defining exposure are the timeframe (induction and
latent periods … In defining exposure under
this scenario, it would be important to define the
cumulative amount of … Creating an Exposure
Definition
Time Window
A key component in defining exposure is the time
period … There is no gold standard for defining the
exposure time window, but the period selected
should be … It then
becomes necessary to justify a more pragmatic
approach to defining exposure given the length
-
effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
January 01, 2013 - time window
Describe the proposed data source(s) and explain how they are adequate and appropriate for defining … its effects relevant to the outcome of interest
Must consider the induction and latent periods when defining … There is no gold standard in defining the exposure time window, but the period selected should be justified … At the same time, practical limitations of the study data should be acknowledged when defining the window … Adherence is another important consideration when defining exposure.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - consistent for current users and the subgroup of incident users—a rare comparison of strategies
for defining … Retrospective Studies:
Tradeoffs for Internal Validity and Applicability
No consensus exists for defining … Ray and colleagues chose a 365-day window without pharmacy fills for the
cohort-defining drug to define … Trialists may not need to consider the washout period or window for defining incident use as
carefully … the cohort’s baseline blood pressure values were measured while patients
were taking their cohort-defining
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/knowledge-brief-2-methods-public-deliberation-130213.pdf
February 01, 2013 - Although all deliberative methodologies
share common characteristics and the
defining features of public … Defining Features of Public
Deliberation? … Public deliberation consists of four defining
elements:
(1) Coming together: A group of
people convenes
-
effectivehealthcare.ahrq.gov/sites/default/files/knowledge-brief-2-methods-public-deliberation-130213.pdf
February 01, 2013 - Although all deliberative methodologies
share common characteristics and the
defining features of public … Defining Features of Public
Deliberation? … Public deliberation consists of four defining
elements:
(1) Coming together: A group of
people convenes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-measures-framework_research.pdf
April 01, 2010 - framework
describes five steps for developing and assessing a quality indicator for end-of-life care, defining … Defining the population or denominator to
which indicators apply may also be problematic in end-of-life … here identifies five steps for developing and assessing a quality
indicator for end-of-life care, defining … Defining the “end-of-life” population poses inherent and practical challenges, including
underdocumentation … Given the earlier discussion on defining
the population for the framework, clearly many of the symptom
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-framework_research.pdf
April 01, 2010 - framework
describes five steps for developing and assessing a quality indicator for end-of-life care, defining … Defining the population or denominator to
which indicators apply may also be problematic in end-of-life … here identifies five steps for developing and assessing a quality
indicator for end-of-life care, defining … Defining the “end-of-life” population poses inherent and practical challenges, including
underdocumentation … Given the earlier discussion on defining
the population for the framework, clearly many of the symptom
-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Defining time 0 for all comparator groups in describing planned analyses is also important. … Internal validity relies on defining appropriate dose, intensity of treatment, and exposure window for … Recognizing the implications and potential biases associated with comparator selection and defining the … group
Treatments approved for multiple indications—appropriate indication will have to be ensured by defining … Defining the indication typically involves a requirement for the presence of certain diagnoses, the absence
-
effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
June 01, 2011 - needed to engage stakeholders and conduct research
Describe methods of engaging stakeholders
*
Defining … Purchasers and payers, such as employers and public and private insurers
*
Engagement Exercise 5:
Defining … retired medical professor
A clinical expert in obstetrics
All of the above
*
Engagement Exercise 5:
Defining … individuals who nominate topics, helps develop research products, or disseminates research products.
*
Defining
-
effectivehealthcare.ahrq.gov/products/eccs-2009/white-paper-2009-1
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - In addition to analyzing
the existing research, the final report will focus on defining the evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/module-ii-stakeholders-and-stakeholder-engagement.pdf
June 01, 2011 - engage stakeholders and
conduct research
§ Describe methods of engaging stakeholders
Slide 6
Defining … Purchasers and payers, such as employers and public and private insurers
Slide 8
Engagement Exercise 5: Defining … Slide 9
Engagement Exercise 5: Defining Stakeholders
Answer: E
Which of the examples of individuals … Slide 10
Defining Stakeholder Engagement
Engagement is a process of giving voice to and involving (
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
July 01, 2012 - Visual display of essential information for defining key questions will also
explicitly define the population … reviewers to describe the context in which medical interventions might be used, and is thus
important for defining … consider the tasks of developing the topic, structuring the review,
developing the key questions, and defining … Chapter 5:
Defining the review question and developing
criteria for including studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-how-to-webinar-text-only.pdf
December 06, 2011 - Speaker notes: As a reminder, we will discuss, first, an overview of deliberative
methods – covering defining … Further, education is a defining feature of deliberation, as I mentioned previously. … Facilitation
Consensus as goal
Speaker notes: There are many distinct deliberative methods with defining … : There are a few key steps to designing deliberative methods including:
1) First, identifying and defining … report are
very specific recommendations about public deliberation as a component of the process
of defining
-
effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-how-to-webinar-text-only.pdf
December 06, 2011 - Speaker notes: As a reminder, we will discuss, first, an overview of deliberative
methods – covering defining … Further, education is a defining feature of deliberation, as I mentioned previously. … Facilitation
Consensus as goal
Speaker notes: There are many distinct deliberative methods with defining … : There are a few key steps to designing deliberative methods including:
1) First, identifying and defining … report are
very specific recommendations about public deliberation as a component of the process
of defining
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - percent,
3
and are higher for women and older
people.
3,4
Different approaches to diagnosing RLS and defining … , 2011
3
Controversy and Uncertainty
Clinicians face substantial uncertainty related to defining … Defining the phenotype of the restless legs syndrome (RLS) using age-of-
symptom-onset. … Controversies and Challenges in Defining the Etiology and Pathophysiology of
Restless Legs Syndrome … comprise a multi-disciplinary group of clinical, content, and methodologic
experts who provide input in defining